Issues in the interpretation of 180-day exclusivity.
Lietzan
Erika
E
Covington & Burling LLP, Washington, DC, USA.
Korn
David E
DE
D016568:Drugs, Generic; D015507:Drugs, Investigational; D006801:Humans; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence; D007880:Legislation, Drug; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D015507:Drugs, Investigational